GI Insights provides updates on screening guidelines, diagnostic options, and management tools for diseases and disorders affecting the gastrointestinal tract. The podcast covers the latest in gastroenterology, including new research and clinical practices. It is produced by ReachMD, a medical education platform.
Episodes
Treating Obesity Today: GLP-1s, Surgery, and Beyond
Guest: Devika Umashanker, MD
Today, obesity treatment often combines medical and surgical strategies rather than following a strict step-by-step approach. GLP-1 therapies, older medications, and procedures like sleeve gastrectomy and gastric bypass all have a place in an individualized, patient-centered plan. Joining Dr. Peter Buch to discuss how we can integrate these approaches int
Managing MASLD in Patients with Obesity
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: David Tendler, MD
Obesity is one of the biggest drivers of metabolic dysfunction-associated steatotic liver disease (MASLD), and the two conditions often need to be managed together. To get patients the results they need, clinicians must know how to screen effectively, rule out other liver conditions, and match treatment to disease st
Staying Ahead of IBD Complications
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Harish Gagneja, MD
Inflammatory bowel disease (IBD) care has shifted from managing symptoms to preventing the long-term consequences of inflammation that a patient may not feel. In this episode of GI Insights, Dr. Peter Buch speaks with Dr. Harish Gagneja about proactive IBD management, from monitoring disease control between colonosc
Gastric Cancer Prevention: A Risk-Based Approach
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Chul Hyun, MD, PhD, MPH
Gastric cancer risk in the United States varies substantially across populations, yet prevention remains largely based on symptoms. Join Dr. Peter Buch and Dr. Chul Hyun, Director of the Gastric Cancer Prevention and Screening Program at the Yale School of Medicine, as they explore how recognizing key risk fact
Managing Early Esophageal and Gastric Cancers: ASGE Recommendations on ESD and EMR
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Vivek Kaul, MD
The American Society for Gastrointestinal Endoscopy (ASGE) recently released a new guideline on when to use endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) in managing early esophageal and gastric cancers. To learn more about when to use each approach, Dr. Peter Buch sits down with guidelin
Screening Modalities for Colon Cancer: What You Need to Know
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Aasma Shaukat, MD, MPH
While fecal immunochemical testing and multitarget stool DNA testing are commonly used to screen for colon cancer, screening rates remain low throughout the United States. With the introduction of blood-based testing modalities, noninvasive colon cancer screening is becoming more accessible than ever. Join host
Assessing Racial Disparities in Colorectal Cancer Screening
Host: Neilanjan Nandi, MD
Guest: Folasade P. May, MD, PhD, MPhil
Racial and ethnic bias prevent patients with colorectal cancer from receiving the highest quality of care. Dr. Neil Nandi is joined by Dr. Fola May, Assistant Professor of Medicine at UCLA, to discuss racial inequalities in access to care and screening for patients with colorectal cancer.
Recapping the 2021 ACG Clinical Guidelines: What’s New in Colorectal Cancer Screening?
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Aasma Shaukat, MD, MPH
Screening for colorectal cancer is unique because there are several screening options available. So how can we balance the latest ACG Clinical Guidelines with patient preferences, cultural context, and insurance coverage to find the best screening option for our patients? Joining Dr. Peter Buch to discuss the up
Strategies for Increasing Colorectal Cancer Screening Rates
Host: Neilanjan Nandi, MD
Guest: Samir Shah, MD
From new guideline recommendations to a concert featuring the American College of Gastroenterology’s official band, a lot is being done to help raise awareness of the importance of screening for colorectal cancer. So how can you help increase screening rates in your own community? Get inspired with these creative initiatives shared
Adenoma Detection Rate: A Prediction of Colorectal Cancer
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Aasma Shaukat, MD, MPH
Adenoma detection rate (ADR) may help us better detect our patients’ risk of developing colorectal cancer. To explore what we need to know about this quality indicator, Dr. Peter Buch joins Dr. Aasma Shaukat from the New York University Grossman School of Medicine to talk about ADR.
Colorectal Cancer in Young Patients: A Multidisciplinary Approach
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: David Liska, MD
Since the 1990s, clinicians have been seeing a significant increase in colorectal cancer among young patients, who are under the age of 50. A multidisciplinary approach is key as diagnostic and treatment considerations are specific to their age. Dive in with Dr. Peter Buch as he’s joined by Dr. David Liska, Section Chi
Developments in Colorectal Cancer Screening: Cell-Free DNA Blood Testing
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: William Grady, MD
While colorectal cancer is the second most common cause of cancer deaths, only a third of people between the ages of 45 and 75 are compliant with screening recommendations. However, cell-free DNA blood-based tests could become a new option for colorectal cancer screening. Dr. Peter Buch sits down with GI expert Dr. W
Making the Right Choices for Patients with Ulcerative Colitis
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: David P. Hudesman, MD
Ulcerative colitis treatment continues to evolve with a growing range of targeted therapies, from S1P modulators to JAK inhibitors. Joining Dr. Peter Buch to discuss how clinicians can personalize care based on disease severity, safety profiles, and patient response is Dr. David Hudesman. He's a Professor in the
Advances in Colorectal Cancer Detection: Exploring the Role of Blood-Based Tests
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Aasma Shaukat, MD, MPH
Blood-based colorectal cancer screening is entering a new era with FDA-approved and emerging tests like Shield and Simple Screen. Alongside updated stool-based options such as Cologuard Plus and CRC-PREVENT, clinicians now have a broader landscape of noninvasive tools to consider and discuss with their patients.
Diagnosing and Treating Hemochromatosis: Expert Insights
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Paul Adams, MD
Hemochromatosis, a genetic condition that causes the body to absorb too much iron from food, often goes unrecognized despite its prevalance. With unique diagnostic and management challenges, it's crucial to understand how it presents, which testing strategies are most effective, and what treatment options are available.
AI in GI: Leveraging CADe to Improve Colonoscopy Performance and Accuracy
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Charles Kahi, MD
Computer-aided detection systems (CADe) are transforming adenoma detection and enhancing colonoscopy quality. Dr. Peter Buch sits down with Dr. Charles Kahi to unpack the latest American Gastroenterological Association (AGA) guideline, evidence from randomized controlled trials, and the practical implications of in
Probiotics in GI Practice: Evidence, Guidelines, and Emerging Innovations
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Alexa Weingarden, MD PhD
Probiotic use in gastroenterology remains a complex and evolving topic, shaped by variable evidence and growing patient demand. Dr. Peter Buch sits down with Dr. Alexa Weingarden to review current data, discuss distinctions between probiotic-related therapies, and explore the clinical utility of microbi
Vomiting Syndromes: A Closer Look at CVS and CHS in Adult Patients
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: David Levinthal, MD, PhD
Cyclic vomiting syndrome (CVS) is often underdiagnosed in adults due to its episodic nature and symptom overlap with other conditions. Dr. David Levinthal joins Dr. Peter Buch to explore key diagnostic criteria, key differences between CVS and cannabinoid hyperemesis syndrome (CHS), and evidence-based treat
Diagnosing and Treating Immune Checkpoint Inhibitor Colitis Effectively
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Yinghong Wang, MD, PhD, MS
Immune checkpoint inhibitor (ICI) colitis comes with unique diagnostic and treatment challenges, which means that recognizing and managing it effectively is key to the best outcomes. Joining Dr. Peter Buch to share her insights on caring for patients with this complex condition is Dr. Yinghong Wang. Dr. Wang
Exploring Technological Advances in GI Training: Practical Insights for Clinicians
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Nabil Mansour, MD
Artificial intelligence, simulation platforms, augmented reality, and other technological innovations are transforming our approach to GI training. In this expert-led discussion, Dr. Peter Buch sits down with Dr. Nabil Mansour to discuss how we can integrate cutting-edge tools into colonoscopy training while preservi
Best Practices for Assessing Minimally Elevated Liver Tests
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Paul Kwo, MD
While sometimes overlooked, minimally elevated liver tests may signal early liver disease or non-hepatic conditions like thyroid dysfunction. As a result, interpreting ALT and AST thresholds, assessing metabolic risk, and reviewing lifestyle factors can help shape a focused diagnostic approach and reduce liver-related com
Reimagining GI Care: Digital Therapeutics for Managing IBS and IBD Symptoms
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Iris Wang, M.D.
From symptom trackers to multidisciplinary app-based platforms, evidence-based digital therapeutics are expanding access to brain-gut behavioral care for patients with irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Dr. Peter Buch sits down with Dr. Iris Wang to discuss the spectrum of available to
Preventive Care Essentials for Patients with IBD: Reviewing ACG Guideline Updates
Guest: Francis Farraye, MD
Host: Peter Buch, MD, FACG, AGAF, FACP
A 2025 update to the American College of Gastroenterology (ACG)'s guideline on preventive care in inflammatory bowel disease (IBD) includes key changes impacting vaccine recommendations, dermatologic screening, and care coordination. Dr. Peter Buch sits down with Dr. Francis Farraye, lead author of this guideline,
Navigating Iron Deficiency Anemia: A Practical Guide for Gastroenterologists
Guest: Thomas DeLoughery, MD
Host: Peter Buch, MD, FACG, AGAF, FACP
Iron deficiency anemia is common in gastroenterology patients and is often underrecognized or suboptimally managed. That's why targeted treatment is essential to improve patient outcomes. In this expert-led discussion, Dr. Peter Buch and Dr. Thomas DeLoughery outline what gastroenterologists need to know about or
Managing Anticoagulants During Acute GI Bleeds: Guideline-Based Best Practices
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Neena Abraham, MD, MS
Knowing how to manage anticoagulants and antithrombotics during acute GI bleeding is essential in preventing avoidable complications, including thromboembolism and delayed hemostasis. Dr. Peter Buch sits down with Dr. Neena Abraham to discuss the latest recommendations from major GI and cardiology soci
Navigating Gastrointestinal Impacts of GLP-1 Receptor Agonists
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Michael Camilleri, MD
GLP-1 receptor agonists are revolutionizing treatment for diabetes and obesity, but their impact on the gastrointestinal tract demands careful clinical attention. Dr. Peter Buch is joined by Dr. Michael Camilleri, Professor of Medicine at the Mayo Foundation for Medical Education and Research in Rochester, Minnes
Optimizing Nutrition in Patients with Chronic Liver Disease
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Ashwani K. Singal MD, MS, FACG, FAASLD, AGAF
Sarcopenia and poor nutrition are often silent threats in chronic liver disease, yet they drastically impact outcomes. Joining Dr. Peter Buch to discuss strategies for recognizing and addressing malnutrition early to improve long-term liver health is Dr. Ashwani Singal. Dr. Singal is a Prof
Tailoring Inflammatory Bowel Disease Care: Selection Criteria and Timing
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: David Fudman, MD
As the advanced treatment landscape for inflammatory bowel disease continues to expand, selecting the right therapies has become more complex, with efficacy, safety, patient preferences, disease phenotypes, and more as factors to consider. Learn how to effectively navigate these therapeutic options for ulcerative coli
Navigating Ostomy Decisions in Ulcerative Colitis and Crohn’s Disease
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Stefan Holubar, MD, MS
When are ostomies necessary in patients with inflammatory bowel disease? Join Dr. Peter Buch and Dr. Stefan Holubar, Director of Research at the IBD Surgery Section at the Cleveland Clinic, as they explore key surgical considerations for both ulcerative colitis and Crohn’s disease, including when to consider tem
Managing Iatrogenic Colon Perforations: Strategies and Considerations
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Mark Benson, MD
Colonic perforations during colonoscopy are rare, but when they occur, taking swift and informed action is critical, particularly to avoid surgical intervention. Joining Dr. Peter Buch to offer his insights on perforation prevention, risk-reduction techniques, and repair strategies is Dr. Mark Benson, an advanced endos
Topical Hemostatic Agents in Endoscopy: A Review of Best Practices and Considerations
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: J. Andy Tau, MD
Topical hemostatic agents play a key role in managing complex bleeding cases, but there’s a lot to keep in mind when selecting which agent to use, like their mechanism and efficacy. Joining Dr. Peter Buch to share top considerations and best practices for using topical hemostatic agents is Dr. J Andy Tau, a board-certi
IBD and Pregnancy: Key Considerations for Patient Management
Guest: Sara Horst, MD, MPH, FACG
While inflammatory bowel disease (IBD) does not typically cause significant problems in pregnancy, it’s still essential to discuss potential impacts with patients and monitor them closely. Dr. Sara Horst, a Professor of Medicine at Vanderbilt University Medical Center, joins GI Insights to discuss important considerations for pregnant patients with IB
Understanding Surgery in Crohn’s Disease: Risk Factors and Complications
Guest: Elisa K. Boden, MD
For many patients with Crohn’s disease, surgery is necessary due to complications like strictures and fistulas. Dr. Elisa Boden explores risk factors and potential complications, which she spoke about at the 2025 Crohn’s and Colitis Congress. Dr. Boden is an Associate Professor of Medicine in the Division of Gastroenterology and Hepatology at Oregon Health a
Advances in IBD Care: Monitoring with Wearable Sensors
Guest: Shalini Prasad, PhD
Guest: Sriram Muthukumar, PhD
Host: Charles Turck, PharmD, BCPS, BCCCP
With the constant ups and downs of inflammatory bowel disease (IBD), consistent monitoring can help provide patient-centric care. Dr. Shalini Prasad and Dr. Sriram Muthukumar, co-founders of EnLiSense, join GI Insights to discuss the wearable device they developed to track inflam
Improving Postsurgical Outcomes in Crohn’s Disease
Guest: Elisa K. Boden, MD
For patients with Crohn’s disease who require surgery, a variety of risk factors are involved in postoperative recovery and disease control. Learn how prehabilitation programs and lifestyle modifications can reduce complications during and after surgery with Dr. Elisa Boden, an Associate Professor of Medicine in the Division of Gastroenterology and Hepatolog
New Guidelines for H. pylori Treatment: 2024 Updates from ACG
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: William Chey, MD
Recent changes to the American College of Gastroenterology’s guidelines on H. pylori treatment provide recommendations for antibiotic susceptibility and optimal patient management. Dr. Peter Buch sits down with the lead author of these guidelines, Dr. William Chey, to learn more about implications for clinical practic
Extraintestinal Manifestations of IBD: Evaluation and Management Strategies
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: David P. Hudesman, MD
Patients with inflammatory bowel disease (IBD) can experience a variety of extraintestinal manifestations (EIMs), including joint and eye pain and skin rashes. Dr. Peter Buch sits down with Dr. David Hudesman to discuss the impacts of these EIMs and explore best practices for patient management. Dr. Hudesman is a
Inflammatory Bowel Disease Management: Choosing the Right Therapy
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: David P. Hudesman, MD
With so many therapeutic options for Crohn’s disease and ulcerative colitis, it can be challenging to determine which one best matches your patient’s needs and preferences. Onset of action, risk of infections, disease location, and therapeutic goals are all key factors in the decision-making process. To learn mor
Crohn’s Disease Care: Diving into the GEM Integrative Risk Score
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Sun-Ho Lee, MD, PhD
Recent research explored the development, validation, and implications of the GEM integrative risk score (GEM-IRS). To learn how this innovative model helps predict the future risk of Crohn’s Disease in healthy first-degree relatives, Dr. Charles Turck speaks with Dr. Sun-Ho Lee, Assistant Professor and clinician
The Role of Neuromodulators in Treating IBS
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Douglas Drossman, MD
While neuromodulators are primarily used to treat psychiatric disorders, they can also help normalize symptoms of irritable bowel syndrome by targeting the gut-brain axis. In fact, about half of all patients with IBS have the potential to benefit from neuromodulators. Dr. Douglass Drossman joins Dr. Peter Buch to
Decoding Bloating: Clinical Assessment and Therapeutic Approaches
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Kyle Staller, MD, MPH
Join Dr. Peter Buch as he speaks with Dr. Kyle Staller, Director of the Gastrointestinal Motility Laboratory at Mass General and Assistant Professor of Medicine at Harvard Medical School, about uncovering the cause of a patient’s bloating and determining how to manage it.
Grappling with Gastroparesis: Key Management Strategies
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Kyle Staller, MD, MPH
The complexities of gastroparesis can make the disease difficult to diagnose and treat. To help us overcome these challenges, Dr. Kyle Staller joins Dr. Peter Buch to share his preferred strategies for managing patients with gastroparesis. Not only is Dr. Staller an Assistant Professor of Medicine at Harvard Univ
Recognizing and Addressing Burnout Among GI Providers
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Brian E. Lacy, MD, PhD
About 50 percent of gastrointestinal providers are experiencing some degree of burnout, which can lead to a variety of personal and professional challenges. Joining Dr. Peter Buch to discuss the signs of burnout and what you can do to mitigate them is Dr. Brian Lacy, lead author of the “Burnout in Gastrointestin
Managing Pouchitis: A Review of the Updated AGA Guidelines
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Edward L. Barnes, MD, MPH
Tune in to learn about the newest clinical practice recommendations for pouchitis and inflammatory pouch disorders. Tune in to learn about the newest clinical practice recommendations for pouchitis and inflammatory pouch disorders. Tune in to learn about the newest clinical practice recommendations for pouchi
SIBO Solutions: A Guide to Recognition, Diagnosis, and Treatment
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Eamonn Quigley, MD
Small intestinal bacterial overgrowth (SIBO) is often overdiagnosed due to misconceptions about symptoms and inaccurate tests. Join Dr. Peter Buch and Dr. Eamonn Quigley as they explore considerations for knowing when and how to diagnose and treat SIBO. Dr. Quigley is the Chief of Gastroenterology and Hepatology and
The Impacts of Analgesics in Patients with Cirrhosis
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Naga Chalasani, MD, FAASLD
It’s recommended that if patients with cirrhosis are using acetaminophen long-term, it should be a limited dosage. But should we be avoiding nonsteroidals in patients with decompensation cirrhosis? To walk through the impacts of analgesics in patients with cirrhosis, join Dr. Peter Buch as he speaks with Dr.
Decoding Risk: Genetic Testing in High-Risk Colon Cancer Patients
Guest: Bryson Katona, MD, PhD
At the 2024 Digestive Disease Week Annual Meeting, Dr. Bryson Katona presented a session, titled “High-Risk Colon Cancer: The ABCs of Genetic Testing.” And now, Dr. Katona is here with Dr. Jody Takemoto to share key insights from his session on genetic testing for patients with high-risk colon cancer. Dr. Katona is the Director of the Gastrointestinal Ca
Diving into the Details of Upadacitinib for UC and Crohn’s Disease
Guest: Andres J. Yarur, MD
Obesity has recently surfaced as an important topic in patients with inflammatory bowel diseases, such as Crohn’s and ulcerative colitis, but historically, these patients have been underweight. This led to the phase III pivotal trials for the use of upadacitinib in patients with moderate to severe ulcerative colitis and Crohn’s disease to see how their base
Living Well with IBD: Proactive Health Maintenance Strategies
Guest: Andres J. Yarur, MD
Health maintenance emphasizes health promotion and disease prevention, which is very important for patients with inflammatory bowel disease (IBD) since they’re at an increased risk of several life-threatening conditions. Tune in to hear Dr. Andres Yarur discuss essential health maintenance strategies for patients with IBD. Dr. Yarur is an Associate Professo
Discussing the Complications of IBS Mimickers
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Michael Camilleri, MD
When it comes to irritable bowel syndrome (IBS), it’s important to keep in mind that there are certain diagnoses clinicians can make to specifically treat the underlying problem that’s causing the symptoms that suggest IBS. To learn more about these complex mimickers, join Dr. Peter Buch as he speaks with Dr. Mic
Elderly Patients with IBD: Management Strategies and Care
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: David P. Hudesman, MD
There’s been an increase in the elderly irritable bowel disease (IBD) population, and it’s estimated that a third of our overall IBD population will soon be over the age of 60. When managing and diagnosing these patients, there’s different factors to consider, like polypharmacy, biological versus chronological ag
Educating Gastrointestinal Patients About the Benefits of Vaccination
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Francis Farraye, MD
Patients with inflammatory bowel disease (IBD) have an increased risk of developing infections, and some may be preventable with a vaccine. Approximately 70 percent of patients with ulcerative colitis or Crohn’s disease will be on immunosuppressive therapy at some point during their treatment course, so it’s best t
Overcoming Controversies of Irritable Bowel Syndrome
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Alexander Ford, MD
Irritable bowel syndrome (IBS) is diagnosed using the ROME 4 criteria, and fortunately, most patients who meet the criteria for IBS clinically are unlikely to have another underlying explanation for their symptoms. However, a common misconception is that IBS is a diagnosis of exclusion, so to learn more about this a
Managing and Treating Patients with Lower GI Bleeding
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: David Wan, MD
Many patients with lower gastrointestinal (GI) bleeding are on anticoagulants, and they may need specific reversal agents depending on what antithrombotic they’re on. Tune into this episode to learn more about the article that dives into the management and treatment of acute lower GI bleeding and the challenges along the
Managing Extraintestinal Manifestations in IBD
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Katherine Falloon, MD
Extraintestinal manifestations (EIMs) that occur in inflammatory bowel disease (IBD) are almost any manifestation that occur outside the gastrointestinal tract. And patients with Crohn’s disease or ulcerative colitis are at an increased risk for developing these manifestations. So to review EIMs in IBD and discus
How Artificial Intelligence Is Changing the Practice of Gastroenterology
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Ali Soroush, MD, MS
Due to recent technological advancements, the use of artificial intelligence to detect a variety of gastroenterological conditions like Barrett’s esophagus, gastric cancer, and colon polyps is increasingly being explored. Learn about the application, benefits, and pitfalls of artificial intelligence in gastroentero
Solutions for Defeating the Negative Impacts of Refractory Constipation
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Joy Liu, MD
For patients with refractory constipation, it’s important to evaluate the psychological impact of these symptoms. Unfortunately, this disorder can easily affect a patient’s quality of life and keep them from doing their normal routine. So what treatment options can help alleviate some of the burden? Dive in with Dr. Peter
Progressing Towards Post-ERCP Pancreatitis Prevention
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Prabhleen Chahal, MD
Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis is the most dreaded complication of this procedure. So what are the patient-related, procedure-related, and operator-related risk factors for developing post-ERCP pancreatitis, and how can we work to prevent it? Join Dr. Peter Buch as he speak
Perianal Crohn’s Disease: The Importance of Multidisciplinary Management
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Benjamin L. Cohen, MD
Guest: Stefan Holubar, MD, MS
Affecting over 25 percent of Crohn's disease patients, perianal disease is a persistent and difficult-to-treat condition. Due to its complex management and significant impact on patients' quality of life, a multidisciplinary approach to care is crucial. Here to discuss the manage
Addressing Alcohol-Associated Liver Disease and Sobriety Pathways
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Paul Kwo, MD
In patients with chronic live disease, consuming alcohol could contribute to progressive liver damage and a variety of cancers. So alcohol consumption should not be a regular occurrence for those who have underlying chronic liver disease. And approximately four percent of patients with alcohol use disorder are referred at
Reviewing Updated Guidelines and Knowledge Gaps for Pouchitis Management
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Edward L. Barnes, MD, MPH
Pouchitis is a common inflammatory complication after ileal pouch-anal anastomosis (J-pouch) surgery, but the why behind patients who develop this condition seems to be unclear. So to dive into the updated guidelines for the management of pouchitis and to also hear about some knowledge gaps in preventing pouc
Addressing the Unique Cases of Portal Vein Thrombosis
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Shilpa Junna, MD
Symptoms of portal vein thrombosis (PVT) are primarily driven by the extent of the obstruction that the PVT is causing, and some of it’s also driven by how quickly the thrombosis has developed. There’s also some cases where symptoms can be nonspecific. So the role of a multidisciplinary team in helping to address this
Exploring New Developments in the Treatment of Recurrent C. Difficile
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Paul Feuerstadt, MD, FACG, AGAF
C. difficile is a major problem in the United States. On top of that, patients who are diagnosed with this infection have the chance of getting caught in a vicious cycle of recurrence. So how can we provide our patients with the best care and work with them to give them the best treatment option? Learn
The Spectrum of Liver Transplantation: Addressing the Needs of Diverse Patient Groups
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Michael Lucey, MD
There are a lot of considerations to keep in mind when it comes to liver transplantation in patients with various diseases, like metabolic-associated stereotactic liver diseases, alcoholic liver disease, hepatitis B and C, and more. Joining Dr. Peter Buch to discuss those key considerations surrounding liver transpla
The Role of Antibiotics in Acute Uncomplicated Appendicitis Treatment
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: David Talan, MD
Until recently, surgery was always utilized for appendicitis, but now, antibiotics are an alternative treatment. Find out who the best candidates are for an antibiotic regimen, the efficacy and safety of this approach to treating acute uncomplicated appendicitis, and more with Dr. Peter Buch and Dr. David Talan, Profes
Harnessing the Power of Social Media in GI
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Benjamin Schmidt, MD
It’s become clear that social media is here to stay, and it’s become a way that people get their information and spread information. Dive into this episode to learn about the benefits and challenges of social media in healthcare from a recently published article with Dr. Peter Buch and Dr. Benjamin Schmidt, Gastro
Postoperative Recurrence of Crohn‘s Disease: Reviewing Monitoring and Treatment Strategies
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Miguel Regueiro, MD
There are a few factors that may predict patients who are more likely to experience postoperative recurrence of Crohn’s disease. So how should we be monitoring our patients for recurrence, and what therapies are available? To learn more, Dr. Peter Buch is joined by Dr. Miguel Regueiro, Chief of Cleveland Clinic’s D
Assessing IBD with Intestinal Ultrasound and Exploring Ongoing Research
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: David T. Rubin, MD
Intestinal ultrasound has become a useful tool in assessing disease progression and pathophysiology of inflammatory bowel disease (IBD). It’s an approach to visualizing the intestines using a transabdominal ultrasound probe to provide real-time information. But could research from the STARDUST substudy on ustekinuma
Hope on the Horizon: The Evaluation and Treatment of Fecal Incontinence
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Kyle Staller, MD, MPH
Unfortunately, there are not a lot of specific pharmacologic agents for incontinent patients; however, using typical antidiarrheal therapies can be helpful for patients who have diarrhea. So what other treatment options should we know about? To learn more, join Dr. Peter Buch as he speaks with Dr. Kyle Staller, A
The Updated Role of Non-Invasive Biomarkers in MASLD
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Julia J Wattacheril, MD, MPH
Non-invasive biomarkers for metabolic dysfunction-associated steatosis liver disease (MASLD) are used to stratify risk and assess disease severity in our patients. In this episode, Dr. Peter Buch is joined by Dr. Julia Wattacheril, Associate Professor of Medicine at Columbia University Irving Medical Cente
The Use of Anticoagulants and Antiplatelet Medications in Cirrhosis
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Naga Chalasani, MD, FAASLD
With the increasing incidence and prevalence of cirrhosis in patients, healthcare professionals have to routinely consider giving anticoagulants to these patients. Understanding how we can safely administer these types of medications to cirrhosis patients is important. To learn more, tune in with Dr. Peter B
Managing Liver Disease in Diabetic Patients: A Comprehensive Approach to Care
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Michael Charlton, MBBS
Liver disease is highly prevalent in patients with type 2 diabetes, and it’s much more likely to be a clinically significant issue in these patients as well. So it’s important to evaluate patients for liver disease during routine check-ups. Dive further into the effects of liver disease in diabetic care with Dr.
Learning About the New Definition of MASLD
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Paul Kwo, MD
Non-alcoholic fatty liver disease connoted that there's no alcohol contribution to the fat and didn't accurately convey the interplay between metabolic-driven cytosis, which can come from insulin resistance and all of the other metabolic dysfunction-associated inflammatory patterns, as well as the contributions of alcohol
The Increasing Incidence of IBD and the Use of Biosimilars
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Shubha Bhat, PharmD
Fortunately, there are a lot of studies that have evaluated biosimilars in inflammatory bowel disease (IBD), and those all confirmed that biosimilars are safe, effective, and do not result in worsening patient outcomes. But are we using biosimilars enough in the treatment of IBD? Dive in with Dr. Mar
10 Recommendations for Managing CIC
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: William Chey, MD
Roughly 1 in 10 Americans suffer with some degree of constipation, and many of those patients suffer with ongoing chronic issues around constipation. So for the first time, the American Gastroenterological Association and the American College of Gastroenterology have released joint recommendations for the management o
Distinguishing Digestive Disorders: How to ID Non-Celiac Gluten Sensitivity
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Marianna Arvanitakis, MD, PhD
Patients with non-celiac gluten sensitivity can experience the same symptoms of those with celiac disease and IBS, complicating the diagnostic process. Find out how you can accurately identify and distinguish non-celiac gluten sensitivity from other digestive disorders with Dr. Peter Buch and Dr. Marianna
Personalizing Care to Fit GERD Patient Needs
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: John Pandolfino, MD, MSCI
There are a wide range of therapeutic options when it comes to personalizing your patient’s treatment approach, such as simple lifestyle modifications all the way to a surgical procedure. To learn more, tune in with Dr. Peter Buch as he speaks with Dr. John Pandolfino, Hans Popper Professor and Chief of Gastr
How to Recognize & Manage an Angry Patient
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Douglas Drossman, MD
We all face angry and disruptive patients from time to time, making it essential to know how to properly de-escalate and handle the situation. That’s why Dr. Peter Buch speaks with Dr. Douglas Drossman, co-author of an article that was published in the American Journal of Gastroenterology titled “De-escalate, Don’
Biomarkers for Ulcerative Colitis Management: A Review of the AGA Guidelines
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Siddharth Singh, MD
How can we use biomarkers to treat patients with ulcerative colitis? That’s the exact question the latest guideline from the American Gastroenterological Association (AGA) sought to address. Learn about this guideline and other best practices with Dr. Peter Buch and Dr. Siddharth Singh, Assistant Professor of Medic
A Look into Liver Transplants
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Alan Bonder, MD
According to the United Network for Organ Sharing (UNOS), more than 95 percent of patients are alive and doing well after a liver transplant. So what else can we learn from UNOS? Join Dr. Peter Buch as he speaks with Dr. Alan Bonder, Assistant Professor of Medicine at Harvard Medical School.
Recommended
ABC News Update
Learn English Fast! English Snacks with Amber - Short Lessons to Speak English Like a Native
این نقطه
This Past Weekend w/ Theo Von
100 Greatest Old Time Detective Stories
Fantasy Flex
Classic Radio Theater with Wyatt Cox
Take Back Your Health®
Solved Murders - True Crime Stories
Old Time Radio - Gunsmoke
ESPN SportsCenter Update
Back to the 80s Radio
